Home > > North America And Global Vaccines Market- Size, Share, Growth Rate, and Forecast
TABLE OF CONTENTS CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: NORTH AMERICA VACCINES MARKET 3.1. OVERVIEW 3.2. NORTH AMERICA 3.2.1. NORTH AMERICA VACCINES MARKET, BY TECHNOLOGY 3.2.2. NORTH AMERICA VACCINES MARKET, BY TYPE 3.2.3. NORTH AMERICA VACCINES MARKET, BY ROUTE OF ADMINISTRATION 3.2.4. NORTH AMERICA VACCINES MARKET, BY COUNTRY 3.2.4.1. US 3.2.4.1.1. US VACCINES MARKET, BY TECHNOLOGY 3.2.4.1.2. US VACCINES MARKET, BY TYPE 3.2.4.1.3. US VACCINES MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.2. CANADA 3.2.4.2.1. CANADA VACCINES MARKET, BY TECHNOLOGY 3.2.4.2.2. CANADA VACCINES MARKET, BY TYPE 3.2.4.2.3. CANADA VACCINES MARKET, BY ROUTE OF ADMINISTRATION 3.3. EUROPE CHAPTER 4: GLOBAL VACCINES MARKET, BY TECHNOLOGY 4.1. OVERVIEW 4.2. CONJUGATE VACCINES 4.2.1. CONJUGATE VACCINES MARKET, BY REGION 4.2.1.1. NORTH AMERICA CONJUGATE VACCINES MARKET, BY COUNTRY 4.2.1.2. EUROPE CONJUGATE VACCINES MARKET, BY COUNTRY 4.2.1.3. ASIA CONJUGATE VACCINES MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA CONJUGATE VACCINES MARKET, BY COUNTRY 4.3. INACTIVATED AND SUBUNIT VACCINES 4.3.1. INACTIVATED AND SUBUNIT VACCINES MARKET, BY REGION 4.3.1.1. NORTH AMERICA INACTIVATED AND SUBUNIT VACCINES MARKET, BY COUNTRY 4.3.1.2. EUROPE INACTIVATED AND SUBUNIT VACCINES MARKET, BY COUNTRY 4.3.1.3. ASIA INACTIVATED AND SUBUNIT VACCINES MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA INACTIVATED AND SUBUNIT VACCINES MARKET, BY COUNTRY 4.4. LIVE ATTENUATED VACCINES 4.4.1. LIVE ATTENUATED VACCINES MARKET, BY REGION 4.4.1.1. NORTH AMERICA LIVE ATTENUATED VACCINES MARKET, BY COUNTRY 4.4.1.2. EUROPE LIVE ATTENUATED VACCINES MARKET, BY COUNTRY 4.4.1.3. ASIA LIVE ATTENUATED VACCINES MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA LIVE ATTENUATED VACCINES MARKET, BY COUNTRY 4.5. RECOMBINANT VACCINES 4.5.1. RECOMBINANT VACCINES MARKET, BY REGION 4.5.1.1. NORTH AMERICA RECOMBINANT VACCINES MARKET, BY COUNTRY 4.5.1.2. EUROPE RECOMBINANT VACCINES MARKET, BY COUNTRY 4.5.1.3. ASIA RECOMBINANT VACCINES MARKET, BY COUNTRY 4.5.1.4. MIDDLE EAST & AFRICA RECOMBINANT VACCINES MARKET, BY COUNTRY 4.6. TOXOID VACCINES 4.6.1. TOXOID VACCINES MARKET, BY REGION 4.6.1.1. NORTH AMERICA TOXOID VACCINES MARKET, BY COUNTRY 4.6.1.2. EUROPE TOXOID VACCINES MARKET, BY COUNTRY 4.6.1.3. ASIA TOXOID VACCINES MARKET, BY COUNTRY 4.6.1.4. MIDDLE EAST & AFRICA TOXOID VACCINES MARKET, BY COUNTRY CHAPTER 5: GLOBAL VACCINES MARKET, BY TYPE 5.1. OVERVIEW 5.2. MONOVALENT VACCINES 5.2.1. MONOVALENT VACCINES MARKET, BY REGION 5.2.1.1. NORTH AMERICA MONOVALENT VACCINES MARKET, BY COUNTRY 5.2.1.2. EUROPE MONOVALENT VACCINES MARKET, BY COUNTRY 5.2.1.3. ASIA MONOVALENT VACCINES MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA MONOVALENT VACCINES MARKET, BY COUNTRY 5.3. MULTIVALENT VACCINES 5.3.1. MULTIVALENT VACCINES MARKET, BY REGION 5.3.1.1. NORTH AMERICA MULTIVALENT VACCINES MARKET, BY COUNTRY 5.3.1.2. EUROPE MULTIVALENT VACCINES MARKET, BY COUNTRY 5.3.1.3. ASIA MULTIVALENT VACCINES MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA MULTIVALENT VACCINES MARKET, BY COUNTRY CHAPTER 6: GLOBAL VACCINES MARKET, BY ROUTE OF ADMINISTRATION 6.1. OVERVIEW 6.2. INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION 6.2.1. INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET, BY REGION 6.2.1.1. NORTH AMERICA INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET, BY COUNTRY 6.2.1.2. EUROPE INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET, BY COUNTRY 6.2.1.3. ASIA INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET, BY COUNTRY 6.2.1.4. MIDDLE EAST & AFRICA INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET, BY COUNTRY 6.3. ORAL ADMINISTRATION 6.3.1. ORAL ADMINISTRATION MARKET, BY REGION 6.3.1.1. NORTH AMERICA ORAL ADMINISTRATION MARKET, BY COUNTRY 6.3.1.2. EUROPE ORAL ADMINISTRATION MARKET, BY COUNTRY 6.3.1.3. ASIA ORAL ADMINISTRATION MARKET, BY COUNTRY 6.3.1.4. MIDDLE EAST & AFRICA ORAL ADMINISTRATION MARKET, BY COUNTRY 6.4. OTHER ROUTES OF ADMINISTRATION 6.4.1. OTHER ROUTES OF ADMINISTRATION MARKET, BY REGION 6.4.1.1. NORTH AMERICA OTHER ROUTES OF ADMINISTRATION MARKET, BY COUNTRY 6.4.1.2. EUROPE OTHER ROUTES OF ADMINISTRATION MARKET, BY COUNTRY 6.4.1.3. ASIA OTHER ROUTES OF ADMINISTRATION MARKET, BY COUNTRY 6.4.1.4. MIDDLE EAST & AFRICA OTHER ROUTES OF ADMINISTRATION MARKET, BY COUNTRY FIGURE 128. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA OTHER ROUTES OF ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF TABLES TABLE 01. GLOBAL VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 02. GLOBAL VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($ MILLION) TABLE 03. TABLE 04. SOURCE: PRIMARY RESEARCH, GOVERNMENT PUBLICATIONS, COMPANY RELEASES, AND 1000IQMR ANALYSISGLOBAL VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 05. GLOBAL VACCINES MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 06. GLOBAL VACCINES MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 07. NORTH AMERICA VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($MILLION) TABLE 08. NORTH AMERICA VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($MILLION) TABLE 09. NORTH AMERICA VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($MILLION) TABLE 10. NORTH AMERICA VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 11. US VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 12. US VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($ MILLION) TABLE 13. US VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 14. CANADA VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 15. CANADA VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($ MILLION) TABLE 16. CANADA VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 17. GLOBAL VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 18. CONJUGATE VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 19. NORTH AMERICA CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 20. EUROPE CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 21. ASIA CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 22. MIDDLE EAST & AFRICA CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 23. INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 24. NORTH AMERICA INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 25. EUROPE INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 26. ASIA INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 27. MIDDLE EAST & AFRICA INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 28. LIVE ATTENUATED VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 29. NORTH AMERICA LIVE ATTENUATED VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 30. EUROPE LIVE ATTENUATED VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. ASIA LIVE ATTENUATED VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. MIDDLE EAST & AFRICA LIVE ATTENUATED VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 33. RECOMBINANT VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 34. NORTH AMERICA RECOMBINANT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 35. EUROPE RECOMBINANT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. ASIA RECOMBINANT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. MIDDLE EAST & AFRICA RECOMBINANT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 38. TOXOID VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 39. NORTH AMERICA TOXOID VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. EUROPE TOXOID VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. ASIA TOXOID VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. MIDDLE EAST & AFRICA TOXOID VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. GLOBAL VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($ MILLION) TABLE 44. MONOVALENT VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 45. NORTH AMERICA MONOVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. EUROPE MONOVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. ASIA MONOVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 48. MIDDLE EAST & AFRICA MONOVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 49. MULTIVALENT VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 50. NORTH AMERICA MULTIVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 51. EUROPE MULTIVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. ASIA MULTIVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. MIDDLE EAST & AFRICA MULTIVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 54. GLOBAL VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 55. INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 56. NORTH AMERICA INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 57. EUROPE INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 58. ASIA INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 59. MIDDLE EAST & AFRICA INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 60. ORAL ADMINISTRATION MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 61. NORTH AMERICA ORAL ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 62. EUROPE ORAL ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 63. ASIA ORAL ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 64. MIDDLE EAST & AFRICA ORAL ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 65. OTHER ROUTES OF ADMINISTRATION MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 66. NORTH AMERICA OTHER ROUTES OF ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 67. EUROPE OTHER ROUTES OF ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 68. ASIA OTHER ROUTES OF ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 69. MIDDLE EAST & AFRICA OTHER ROUTES OF ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 01. TOP INVESTMENT POCKETS: GLOBAL VACCINES MARKET VALUE, BY REGION, 2023-2030, ($MILLION) FIGURE 02. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL VACCINES MARKET VALUE, BY REGION, 2023-2030, ($MILLION) FIGURE 03. TOP INVESTMENT POCKETS: NORTH AMERICA VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($MILLION) FIGURE 04. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($MILLION) FIGURE 05. TOP INVESTMENT POCKETS: NORTH AMERICA VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($MILLION) FIGURE 06. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($MILLION) FIGURE 07. TOP INVESTMENT POCKETS: NORTH AMERICA VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($MILLION) FIGURE 08. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($MILLION) FIGURE 09. TOP INVESTMENT POCKETS: NORTH AMERICA VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 10. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 11. TOP INVESTMENT POCKETS: US VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) FIGURE 12. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: US VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) FIGURE 13. TOP INVESTMENT POCKETS: US VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($ MILLION) FIGURE 14. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: US VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($ MILLION) FIGURE 15. TOP INVESTMENT POCKETS: US VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) FIGURE 16. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: US VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) FIGURE 17. TOP INVESTMENT POCKETS: CANADA VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) FIGURE 18. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: CANADA VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) FIGURE 19. TOP INVESTMENT POCKETS: CANADA VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($ MILLION) FIGURE 20. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: CANADA VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($ MILLION) FIGURE 21. TOP INVESTMENT POCKETS: CANADA VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) FIGURE 22. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: CANADA VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) FIGURE 23. TOP INVESTMENT POCKETS: GLOBAL VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) FIGURE 24. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) FIGURE 25. TOP INVESTMENT POCKETS: CONJUGATE VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 26. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: CONJUGATE VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 27. TOP INVESTMENT POCKETS: NORTH AMERICA CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 28. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 29. TOP INVESTMENT POCKETS: EUROPE CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 30. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 31. TOP INVESTMENT POCKETS: ASIA CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 32. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 33. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 34. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 35. TOP INVESTMENT POCKETS: INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 36. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 37. TOP INVESTMENT POCKETS: NORTH AMERICA INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 38. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 39. TOP INVESTMENT POCKETS: EUROPE INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 40. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 41. TOP INVESTMENT POCKETS: ASIA INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 42. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 43. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 44. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 45. TOP INVESTMENT POCKETS: LIVE ATTENUATED VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 46. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: LIVE ATTENUATED VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 47. TOP INVESTMENT POCKETS: NORTH AMERICA LIVE ATTENUATED VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 48. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA LIVE ATTENUATED VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 49. TOP INVESTMENT POCKETS: EUROPE LIVE ATTENUATED VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 50. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE LIVE ATTENUATED VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 51. TOP INVESTMENT POCKETS: ASIA LIVE ATTENUATED VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 52. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA LIVE ATTENUATED VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 53. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA LIVE ATTENUATED VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 54. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA LIVE ATTENUATED VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 55. TOP INVESTMENT POCKETS: RECOMBINANT VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 56. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: RECOMBINANT VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 57. TOP INVESTMENT POCKETS: NORTH AMERICA RECOMBINANT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 58. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA RECOMBINANT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 59. TOP INVESTMENT POCKETS: EUROPE RECOMBINANT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 60. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE RECOMBINANT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 61. TOP INVESTMENT POCKETS: ASIA RECOMBINANT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 62. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA RECOMBINANT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 63. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA RECOMBINANT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 64. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA RECOMBINANT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 65. TOP INVESTMENT POCKETS: TOXOID VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 66. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: TOXOID VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 67. TOP INVESTMENT POCKETS: NORTH AMERICA TOXOID VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 68. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA TOXOID VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 69. TOP INVESTMENT POCKETS: EUROPE TOXOID VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 70. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE TOXOID VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 71. TOP INVESTMENT POCKETS: ASIA TOXOID VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 72. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA TOXOID VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 73. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA TOXOID VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 74. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA TOXOID VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 75. TOP INVESTMENT POCKETS: GLOBAL VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($ MILLION) FIGURE 76. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($ MILLION) FIGURE 77. TOP INVESTMENT POCKETS: MONOVALENT VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 78. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MONOVALENT VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 79. TOP INVESTMENT POCKETS: NORTH AMERICA MONOVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 80. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA MONOVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 81. TOP INVESTMENT POCKETS: EUROPE MONOVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 82. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE MONOVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 83. TOP INVESTMENT POCKETS: ASIA MONOVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 84. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA MONOVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 85. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA MONOVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 86. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA MONOVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 87. TOP INVESTMENT POCKETS: MULTIVALENT VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 88. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MULTIVALENT VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 89. TOP INVESTMENT POCKETS: NORTH AMERICA MULTIVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 90. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA MULTIVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 91. TOP INVESTMENT POCKETS: EUROPE MULTIVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 92. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE MULTIVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 93. TOP INVESTMENT POCKETS: ASIA MULTIVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 94. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA MULTIVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 95. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA MULTIVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 96. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA MULTIVALENT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 97. TOP INVESTMENT POCKETS: GLOBAL VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) FIGURE 98. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) FIGURE 99. TOP INVESTMENT POCKETS: INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 100. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 101. TOP INVESTMENT POCKETS: NORTH AMERICA INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 102. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 103. TOP INVESTMENT POCKETS: EUROPE INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 104. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 105. TOP INVESTMENT POCKETS: ASIA INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 106. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 107. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 108. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 109. TOP INVESTMENT POCKETS: ORAL ADMINISTRATION MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 110. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ORAL ADMINISTRATION MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 111. TOP INVESTMENT POCKETS: NORTH AMERICA ORAL ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 112. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA ORAL ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 113. TOP INVESTMENT POCKETS: EUROPE ORAL ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 114. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE ORAL ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 115. TOP INVESTMENT POCKETS: ASIA ORAL ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 116. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA ORAL ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 117. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA ORAL ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 118. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA ORAL ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 119. TOP INVESTMENT POCKETS: OTHER ROUTES OF ADMINISTRATION MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 120. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: OTHER ROUTES OF ADMINISTRATION MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 121. TOP INVESTMENT POCKETS: NORTH AMERICA OTHER ROUTES OF ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 122. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA OTHER ROUTES OF ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 123. TOP INVESTMENT POCKETS: EUROPE OTHER ROUTES OF ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 124. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE OTHER ROUTES OF ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 125. TOP INVESTMENT POCKETS: ASIA OTHER ROUTES OF ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 126. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA OTHER ROUTES OF ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 127. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA OTHER ROUTES OF ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 128. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA OTHER ROUTES OF ADMINISTRATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF FIGURES FIGURE 01. TOP INVESTMENT POCKETS: GLOBAL VACCINES MARKET VALUE, BY REGION, 2023-2030, ($MILLION) FIGURE 02. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL VACCINES MARKET VALUE, BY REGION, 2023-2030, ($MILLION) FIGURE 03. TOP INVESTMENT POCKETS: NORTH AMERICA VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($MILLION) FIGURE 04. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($MILLION) FIGURE 05. TOP INVESTMENT POCKETS: NORTH AMERICA VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($MILLION) FIGURE 06. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($MILLION) FIGURE 07. TOP INVESTMENT POCKETS: NORTH AMERICA VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($MILLION) FIGURE 08. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($MILLION) FIGURE 09. TOP INVESTMENT POCKETS: NORTH AMERICA VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 10. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 11. TOP INVESTMENT POCKETS: US VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) FIGURE 12. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: US VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) FIGURE 13. TOP INVESTMENT POCKETS: US VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($ MILLION) FIGURE 14. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: US VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($ MILLION) FIGURE 15. TOP INVESTMENT POCKETS: US VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) FIGURE 16. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: US VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) FIGURE 17. TOP INVESTMENT POCKETS: CANADA VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) FIGURE 18. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: CANADA VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) FIGURE 19. TOP INVESTMENT POCKETS: CANADA VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($ MILLION) FIGURE 20. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: CANADA VACCINES MARKET VALUE, BY TYPE, 2023-2030, ($ MILLION) FIGURE 21. TOP INVESTMENT POCKETS: CANADA VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) FIGURE 22. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: CANADA VACCINES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) FIGURE 23. TOP INVESTMENT POCKETS: GLOBAL VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) FIGURE 24. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL VACCINES MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) FIGURE 25. TOP INVESTMENT POCKETS: CONJUGATE VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 26. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: CONJUGATE VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 27. TOP INVESTMENT POCKETS: NORTH AMERICA CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 28. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 29. TOP INVESTMENT POCKETS: EUROPE CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 30. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 31. TOP INVESTMENT POCKETS: ASIA CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 32. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 33. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 34. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA CONJUGATE VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 35. TOP INVESTMENT POCKETS: INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 36. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 37. TOP INVESTMENT POCKETS: NORTH AMERICA INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 38. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 39. TOP INVESTMENT POCKETS: EUROPE INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 40. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 41. TOP INVESTMENT POCKETS: ASIA INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 42. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 43. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 44. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA INACTIVATED AND SUBUNIT VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 45. TOP INVESTMENT POCKETS: LIVE ATTENUATED VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 46. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: LIVE ATTENUATED VACCINES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 47. TOP INVESTMENT POCKETS: NORTH AMERICA LIVE ATTENUATED VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 48. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA LIVE ATTENUATED VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 49. TOP INVESTMENT POCKETS: EUROPE LIVE ATTENUATED VACCINES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 50. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EURO